Connor, Clark & Lunn Investment Management (CC&L)’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.8M | Buy |
+48,589
| New | +$3.8M | 0.01% | 663 |
|
|
2025
Q1 | – | Sell |
-380,103
| Closed | -$28.1M | – | 1474 |
|
|
2024
Q4 | $28.1M | Buy |
380,103
+166,403
| +78% | +$12.3M | 0.13% | 128 |
|
|
2024
Q3 | $14.1M | Buy |
213,700
+51,896
| +32% | +$3.42M | 0.07% | 215 |
|
|
2024
Q2 | $14.9M | Buy |
161,804
+157,043
| +3,299% | +$14.5M | 0.06% | 226 |
|
|
2024
Q1 | $455K | Sell |
4,761
-270,756
| -98% | -$25.9M | ﹤0.01% | 1139 |
|
|
2023
Q4 | $21M | Sell |
275,517
-245,912
| -47% | -$18.8M | 0.1% | 169 |
|
|
2023
Q3 | $36.1M | Buy |
521,429
+333,841
| +178% | +$23.1M | 0.19% | 103 |
|
|
2023
Q2 | $17.7M | Buy |
187,588
+157,703
| +528% | +$14.9M | 0.09% | 171 |
|
|
2023
Q1 | $2.47M | Sell |
29,885
-288,880
| -91% | -$23.9M | 0.01% | 509 |
|
|
2022
Q4 | $23.8M | Buy |
318,765
+246,991
| +344% | +$18.4M | 0.14% | 121 |
|
|
2022
Q3 | $5.93M | Sell |
71,774
-10,196
| -12% | -$843K | 0.04% | 289 |
|
|
2022
Q2 | $7.8M | Sell |
81,970
-1,674
| -2% | -$159K | 0.05% | 232 |
|
|
2022
Q1 | $9.85M | Buy |
+83,644
| New | +$9.85M | 0.05% | 225 |
|
|
2021
Q4 | – | Sell |
-235,227
| Closed | -$26.6M | – | 1117 |
|
|
2021
Q3 | $26.6M | Sell |
235,227
-19,536
| -8% | -$2.21M | 0.14% | 127 |
|
|
2021
Q2 | $26.4M | Buy |
254,763
+81,374
| +47% | +$8.43M | 0.13% | 143 |
|
|
2021
Q1 | $14.5M | Buy |
173,389
+135,836
| +362% | +$11.4M | 0.08% | 185 |
|
|
2020
Q4 | $3.43M | Sell |
37,553
-17,622
| -32% | -$1.61M | 0.02% | 407 |
|
|
2020
Q3 | $4.4M | Buy |
+55,175
| New | +$4.4M | 0.03% | 332 |
|
|
2020
Q2 | – | Sell |
-20,500
| Closed | -$3.87M | – | 1062 |
|
|
2020
Q1 | $3.87M | Buy |
+20,500
| New | +$3.87M | 0.03% | 292 |
|
|
2015
Q3 | – | Sell |
-7,125
| Closed | -$1.02M | – | 746 |
|
|
2015
Q2 | $1.02M | Sell |
7,125
-24,475
| -77% | -$3.49M | 0.01% | 338 |
|
|
2015
Q1 | $4.5M | Buy |
31,600
+2,400
| +8% | +$342K | 0.04% | 158 |
|
|
2014
Q4 | $3.72M | Buy |
29,200
+6,200
| +27% | +$790K | 0.03% | 177 |
|
|
2014
Q3 | $2.35M | Buy |
+23,000
| New | +$2.35M | 0.02% | 197 |
|